---
title: IFNγ mediates the resistance of tumor cells to distinct NK cell subsets
date: '2024-07-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38955423/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240703182124&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Our data reveal that in the context of NK cells, IFNγ induces
  the resistance of tumor cells by the upregulation of classical and non-classical
  MHC-I. Moreover, we reveal insights into NK cell subset reactivity and propose a
  therapeutic strategy involving combinational monalizumab/lirilumab/DX9 treatment
  to fully restore the antitumor response across NK cell ...'
disable_comments: true
---
CONCLUSION: Our data reveal that in the context of NK cells, IFNγ induces the resistance of tumor cells by the upregulation of classical and non-classical MHC-I. Moreover, we reveal insights into NK cell subset reactivity and propose a therapeutic strategy involving combinational monalizumab/lirilumab/DX9 treatment to fully restore the antitumor response across NK cell ...